Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease
暂无分享,去创建一个
P. Scheltens | F. Barkhof | W. Flier | A. Gouw | B. Tijms | C. Teunissen | S. Verfaillie | M. T. Kate | A. Borta
[1] A. Simmons,et al. Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease , 2016, Cerebral cortex.
[2] Frederik Barkhof,et al. Gray matter network disruptions and amyloid beta in cognitively normal adults , 2016, Neurobiology of Aging.
[3] Harald Hampel,et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. , 2015, Brain : a journal of neurology.
[4] Norbert Schuff,et al. Directed Network Motifs in Alzheimer’s Disease and Mild Cognitive Impairment , 2015, PloS one.
[5] David Phillips,et al. Graph theoretic analysis of structural connectivity across the spectrum of Alzheimer's disease: The importance of graph creation methods , 2015, NeuroImage: Clinical.
[6] Andrew J. Saykin,et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.
[7] Cornelis J. Stam,et al. Single-Subject Gray Matter Graph Properties and Their Relationship with Cognitive Impairment in Early- and Late-Onset Alzheimer's Disease , 2014, Brain Connect..
[8] Frederik Barkhof,et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.
[9] W. M. van der Flier,et al. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. , 2014, Journal of Alzheimer's disease : JAD.
[10] W. M. van der Flier,et al. Preclinical AD predicts decline in memory and executive functions in subjective complaints , 2013, Neurology.
[11] Bruce Fischl,et al. Genetic topography of brain morphology , 2013, Proceedings of the National Academy of Sciences.
[12] C. Stam,et al. Alzheimer's disease: connecting findings from graph theoretical studies of brain networks , 2013, Neurobiology of Aging.
[13] E. Bullmore,et al. Imaging structural co-variance between human brain regions , 2013, Nature Reviews Neuroscience.
[14] Y. Lui,et al. Small-World Properties in Mild Cognitive Impairment and Early Alzheimer’s Disease: A Cortical Thickness MRI Study , 2013, ISRN geriatrics.
[15] W. M. van der Flier,et al. Single-Subject Grey Matter Graphs in Alzheimer's Disease , 2013, PloS one.
[16] E. Bullmore,et al. The Convergence of Maturational Change and Structural Covariance in Human Cortical Networks , 2013, The Journal of Neuroscience.
[17] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[18] Olivier Salvado,et al. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.
[19] D. Willshaw,et al. Cerebral Cortex doi:10.1093/cercor/bhr221 Cerebral Cortex Advance Access published September 21, 2011 Similarity-Based Extraction of Individual Networks from Gray Matter MRI Scans , 2022 .
[20] D. Shen,et al. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features , 2012, Neurobiology of Aging.
[21] Alan C. Evans,et al. Convergence and divergence of thickness correlations with diffusion connections across the human cerebral cortex , 2012, NeuroImage.
[22] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[23] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[24] Yuan Zhou,et al. Abnormal Cortical Networks in Mild Cognitive Impairment and Alzheimer's Disease , 2010, PLoS Comput. Biol..
[25] Andreas Daffertshofer,et al. Comparing Brain Networks of Different Size and Connectivity Density Using Graph Theory , 2010, PloS one.
[26] Olaf Sporns,et al. Complex network measures of brain connectivity: Uses and interpretations , 2010, NeuroImage.
[27] W. M. van der Flier,et al. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. , 2010, Clinical chemistry.
[28] Alan C. Evans,et al. Variance decomposition of MRI-based covariance maps using genetically informative samples and structural equation modeling , 2009, NeuroImage.
[29] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[30] E. Bullmore,et al. Hierarchical Organization of Human Cortical Networks in Health and Schizophrenia , 2008, The Journal of Neuroscience.
[31] Alan C. Evans,et al. Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[32] Alan C. Evans,et al. Mapping anatomical correlations across cerebral cortex (MACACC) using cortical thickness from MRI , 2006, NeuroImage.
[33] Karl J. Friston,et al. Structural Covariance in the Human Cortex , 2005, The Journal of Neuroscience.
[34] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[35] K. Sneppen,et al. Specificity and Stability in Topology of Protein Networks , 2002, Science.
[36] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[37] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[38] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[39] D. Purves,et al. Correlated Size Variations in Human Visual Cortex, Lateral Geniculate Nucleus, and Optic Tract , 1997, The Journal of Neuroscience.
[40] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[41] B. Mittelman,et al. On control. , 1979, Dental management.